Robin Shane Readnour is a director of AN2 Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Jan 24 | ANTX AN2 Therapeutics | Common Stock | Sell | Dispose S | Yes | Yes | 21.91 | 719 | 15.75 k | 485,073 |
12 Jan 24 | ANTX AN2 Therapeutics | Common Stock | Sell | Dispose S | Yes | Yes | 21.92 | 706 | 15.48 k | 414,788 |
10 Jan 24 | ANTX AN2 Therapeutics | Common Stock | Sell | Dispose S | Yes | Yes | 21.92 | 1,800 | 39.46 k | 485,792 |
10 Jan 24 | ANTX AN2 Therapeutics | Common Stock | Sell | Dispose S | Yes | Yes | 21.93 | 1,869 | 40.99 k | 415,494 |
7 Jun 23 | ANTX AN2 Therapeutics | Stock Option (right to buy) Common Stock | Grant | Acquire A | No | No | 5.91 | 23,742 | 140.32 k | 23,742 |